US Stock MarketDetailed Quotes

AVXL Anavex Life Sciences

Watchlist
  • 3.850
  • +0.090+2.39%
Close May 3 16:00 ET
  • 3.820
  • -0.030-0.78%
Post 19:31 ET
316.13MMarket Cap-7129P/E (TTM)

Anavex Life Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
-2.77%153.2M
102.14%153.34M
-Cash and cash equivalents
0.10%143.77M
1.25%151.02M
1.25%151.02M
1.06%154.82M
0.08%153.47M
-4.98%143.62M
-1.94%149.16M
-1.94%149.16M
-2.77%153.2M
102.14%153.34M
Receivables
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
-65.05%3.19M
-65.05%3.19M
-23.73%6.56M
-11.72%6.47M
-Taxes receivable
-13.32%3.55M
-15.16%2.71M
-15.16%2.71M
-66.99%2.17M
-26.76%4.74M
-23.78%4.09M
-65.05%3.19M
-65.05%3.19M
-23.73%6.56M
-11.72%6.47M
Other current assets
15.31%756K
84.46%653K
84.46%653K
79.14%827.57K
111.31%981.77K
73.51%655.64K
-4.82%354K
-4.82%354K
--461.96K
--464.61K
Total current assets
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.71M
-5.51%152.71M
-3.72%160.22M
91.78%160.28M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-0.20%148.07M
1.10%154.39M
1.10%154.39M
-1.50%157.81M
-0.68%159.19M
-5.43%148.37M
-5.51%152.71M
-5.51%152.71M
-3.72%160.22M
91.78%160.28M
Liabilities
Current liabilities
Payables
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
-19.30%3.83M
-19.30%3.83M
-25.13%3.13M
-28.05%2.63M
-accounts payable
-18.84%4.29M
12.99%4.32M
12.99%4.32M
32.81%4.15M
138.68%6.28M
14.10%5.29M
-19.30%3.83M
-19.30%3.83M
-25.13%3.13M
-28.05%2.63M
Current accrued expenses
-5.05%5.5M
27.72%5.94M
27.72%5.94M
0.18%5.03M
17.09%5.25M
36.49%5.79M
5.31%4.65M
5.31%4.65M
7.97%5.02M
23.91%4.48M
Current deferred liabilities
0.03%917K
106.53%917K
106.53%917K
106.56%916.76K
106.56%916.76K
106.56%916.76K
0.04%444K
0.04%444K
0.00%443.83K
-8.89%443.83K
Current liabilities
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.41%10.21M
-5.41%10.21M
2.27%9.48M
3.96%8.07M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-5.68%12.5M
22.71%12.53M
22.71%12.53M
16.56%11.06M
73.72%14.02M
25.83%13.25M
-5.41%10.21M
-5.41%10.21M
2.27%9.48M
3.96%8.07M
Shareholders'equity
Share capital
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
2.74%78K
2.74%78K
3.72%77.94K
10.18%77.16K
-common stock
5.08%82K
5.13%82K
5.13%82K
4.42%81.39K
3.98%80.24K
2.46%78.03K
2.74%78K
2.74%78K
3.72%77.94K
10.18%77.16K
-Preferred stock
----
----
----
----
--0
----
----
----
--0
----
Retained earnings
-16.69%-301.69M
-19.35%-293.07M
-19.35%-293.07M
-22.33%-282.92M
-24.09%-271.64M
-24.02%-258.54M
-24.28%-245.56M
-24.28%-245.56M
-24.43%-231.27M
-24.60%-218.91M
Paid-in capital
11.08%437.18M
12.08%434.84M
12.08%434.84M
12.48%429.6M
12.19%416.73M
10.94%393.58M
11.38%387.98M
11.38%387.98M
11.37%381.93M
47.73%371.44M
Other equity interest
----
----
----
----
----
----
----
----
----
---403.7K
Total stockholders'equity
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-5.52%142.49M
-4.08%150.74M
100.77%152.21M
Total equity
0.33%135.58M
-0.45%141.85M
-0.45%141.85M
-2.64%146.75M
-4.63%145.17M
-7.68%135.12M
-5.52%142.49M
-5.52%142.49M
-4.08%150.74M
100.77%152.21M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M-2.77%153.2M102.14%153.34M
-Cash and cash equivalents 0.10%143.77M1.25%151.02M1.25%151.02M1.06%154.82M0.08%153.47M-4.98%143.62M-1.94%149.16M-1.94%149.16M-2.77%153.2M102.14%153.34M
Receivables -13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M-65.05%3.19M-65.05%3.19M-23.73%6.56M-11.72%6.47M
-Taxes receivable -13.32%3.55M-15.16%2.71M-15.16%2.71M-66.99%2.17M-26.76%4.74M-23.78%4.09M-65.05%3.19M-65.05%3.19M-23.73%6.56M-11.72%6.47M
Other current assets 15.31%756K84.46%653K84.46%653K79.14%827.57K111.31%981.77K73.51%655.64K-4.82%354K-4.82%354K--461.96K--464.61K
Total current assets -0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M-5.51%152.71M-5.51%152.71M-3.72%160.22M91.78%160.28M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -0.20%148.07M1.10%154.39M1.10%154.39M-1.50%157.81M-0.68%159.19M-5.43%148.37M-5.51%152.71M-5.51%152.71M-3.72%160.22M91.78%160.28M
Liabilities
Current liabilities
Payables -18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M-19.30%3.83M-19.30%3.83M-25.13%3.13M-28.05%2.63M
-accounts payable -18.84%4.29M12.99%4.32M12.99%4.32M32.81%4.15M138.68%6.28M14.10%5.29M-19.30%3.83M-19.30%3.83M-25.13%3.13M-28.05%2.63M
Current accrued expenses -5.05%5.5M27.72%5.94M27.72%5.94M0.18%5.03M17.09%5.25M36.49%5.79M5.31%4.65M5.31%4.65M7.97%5.02M23.91%4.48M
Current deferred liabilities 0.03%917K106.53%917K106.53%917K106.56%916.76K106.56%916.76K106.56%916.76K0.04%444K0.04%444K0.00%443.83K-8.89%443.83K
Current liabilities -5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M-5.41%10.21M-5.41%10.21M2.27%9.48M3.96%8.07M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -5.68%12.5M22.71%12.53M22.71%12.53M16.56%11.06M73.72%14.02M25.83%13.25M-5.41%10.21M-5.41%10.21M2.27%9.48M3.96%8.07M
Shareholders'equity
Share capital 5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K2.74%78K2.74%78K3.72%77.94K10.18%77.16K
-common stock 5.08%82K5.13%82K5.13%82K4.42%81.39K3.98%80.24K2.46%78.03K2.74%78K2.74%78K3.72%77.94K10.18%77.16K
-Preferred stock ------------------0--------------0----
Retained earnings -16.69%-301.69M-19.35%-293.07M-19.35%-293.07M-22.33%-282.92M-24.09%-271.64M-24.02%-258.54M-24.28%-245.56M-24.28%-245.56M-24.43%-231.27M-24.60%-218.91M
Paid-in capital 11.08%437.18M12.08%434.84M12.08%434.84M12.48%429.6M12.19%416.73M10.94%393.58M11.38%387.98M11.38%387.98M11.37%381.93M47.73%371.44M
Other equity interest ---------------------------------------403.7K
Total stockholders'equity 0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M-5.52%142.49M-5.52%142.49M-4.08%150.74M100.77%152.21M
Total equity 0.33%135.58M-0.45%141.85M-0.45%141.85M-2.64%146.75M-4.63%145.17M-7.68%135.12M-5.52%142.49M-5.52%142.49M-4.08%150.74M100.77%152.21M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg